The angiogenesis inhibitor, endostatin, does not affect murine cutaneous wound healing

Journal of Surgical Research

Volumn 91, Issue 1, 2000, Pages 26-31

  Berger, Adam C ^a   Feldman, Andrew L ^a   Gnant, Michael F X ^a   Kruger, Erwin A ^a   Sim, B Kim Lee ^b   Hewitt, Stephen ^a   Figg, William D ^a   Alexander, H Richard ^a   Libutti, Steven K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b ENTREMED INC   (United States)

Author keywords

Angiogenesis; Endostatin; Endothelial cells; Tensile strength

Indexed keywords

ENDOSTATIN;

ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN INJURY; VASCULAR ENDOTHELIUM; WOUND HEALING;

EID: 0034212417     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.2000.5890     Document Type: Article

References (18)

1. Lawrence W. T., Diegelmann R. F. Growth actors in wound healing. Clin. Dermatol. 12:1999;157.
2. Arbiser J. L. Angiogenesis and the skin: A primer. J. Am. Acad. Dermatol. 34:1996;486.
3. Klein S. A., Bond S. J., Gupta S. C., Yacoub O. A., Anderson G. L. Angiogenesis inhibitor TNP-470 inhibits murine cutaneous wound healing. J. Surg. Res. 82:1999;268.
4. Tanaka H., Taniguchi H. J., Mugitani T., Koishi Y., Masuyama M., Koyama H., Hoshima M., Takahashi T. Angiogenesis inhibitor TNP-470 prevents implanted liver metastases after partial hepatectomy in an experimental model without impairing wound healing. Br. J. Surg. 83:1996;1444.
5. Brem J., Gresser I., Grossfeld J., Folkman J. The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis. J. Pediatr. Surg. 28:1993;1253.
6. O'Reilly M. S., Boehm T., Shing Y., Fukai N., Vasios G., Lane W. S., Flynn E., Birkhead J. R., Olsen B. R., Folkman J. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell. 88:1997;277.
7. Obeso J., Weber J., Auerbach R. A hemangioendothelioma-derived cell line: Its use as a model for the study of endothelial cell biology. Lab. Invest. 63:1990;259.
8. Rehr M., Pihlajaniemi T. a1 (XVII), a collagen chain with frequent interruptions in the collagenous sequence, a distinct tissue distribution, and a homology with type XV collagen. Proc. Natl. Acad. Sci. USA. 91:1994;4234.
9. Boehm T., Folkman J., Browder T., O'Reilly M. S. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature. 390:1997;404.
10. Dhanabal M., Volk R., Ramchandran R., Simons M., Sukhatme V. P. Cloning, expression, and in vitro activity of human endostatin. Biochem. Biophys. Res. Commun. 258:1999;345.
11. Boehm T., Pirie-Shepherd S., Trinh L.-B., Shiloach J., Folkman J. Disruption of the KEX1 gene in Pichia pastoris allows expression of full-length murine and human endostatin. Yeast. 15:1999;563.
12. Sim B. K. L., Fogler W. E., Zhou X. H., Liang H., Madsen J. W., Luu K., O'Reilly M. S., Tomaszewsky J. E., Fortier A. H. Zinc ligand-disrupted recombinant human endostatin: Potent inhibition of tumor growth, safety and pharmacokinetic profile. Angiogenesis. 3:1999;41.
13. Moulton K. S., Heller E., Konerding M. A., Flynn E., Paplinski W., Folkman J. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation. 99:1999;1726.
14. Hohenester E., Sasaki T., OIsen B. R., Timpl R. Crystal structure of the angiogenesis inhibitor endostatin at 1. EMBO J. 17:1998;1656.
15. Chang Z., Choon A., Friedl A. Endostatin binds to blood vessel in situ independent of heparin sulfate and does not compete for fibroblast growth factor-2 binding. Am. J. Pathol. 155:1999;70.
16. Dhanabal M., Ramchandran R., Waterman M. J. F., Lu H., Knebelmann B., Segal M., Sukhatme V. P. Endostatin induces endothelial cell apoptosis. J. Biol. Chem. 17:1999;11721.
17. Lucas R., Holmgren L., Garcia I., Jimenez B., Mandriota S. J., Borlat F., Sim B. K., Wu Z., Grau G. E., Shing Y., Soff G. A., Bouck N., Pepper M. S. Multiple forms of angiostatin induce apoptosis in endothelial cells. Blood. 92:1998;4730.
18. Taddei L., Chiarugi P., Brogelli L., Cirri P., Magnelli L., Raugei G., Ziche M., Granger H. J., Chiarugi V., Ramponi G. Inhibitory effect of full-length human endostatin on in vitro angiogenesis. Biochem. Biophys. Res. Commun. 263:1999;340.